External cardioversion in patients with persistent atrial fibrillation: A reappraisal of the effects of electrode pad position and transthoracic impedance on cardioversion success

Japanese Heart Journal

Volumn 44, Issue 6, 2003, Pages 921-932

  Chen, Chien Jen ^a   Guo, G Bih Fang ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Atrial fibrillation; Cardioversion; Electrode pad position; Impedance

Indexed keywords

HEPARIN; AMIODARONE; ANTIARRHYTHMIC AGENT;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; CARDIOVERSION; CLAVICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; ENERGY CONSUMPTION; FEMALE; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HUMAN; IMPEDANCE; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; AGED; ELECTRODE; IMPEDANCE CARDIOGRAPHY; INSTRUMENTATION; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PROSPECTIVE STUDY;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CARDIOGRAPHY, IMPEDANCE; ELECTRIC COUNTERSHOCK; ELECTRODES; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 1242331452     PISSN: 00214868     EISSN: 1348673X     Source Type: Journal    
DOI: 10.1536/jhj.44.921     Document Type: Article

References (27)

1. Yurchak PM, Williams SV, Achord JL, et al. Clinical competence in elective direct current (DC) cardiversion. A statement for physicians from AHA/ACC/ACP task force on clinical privileges in cardiology. Circulation 1993; 88: 342-5.
2. Lip GYH, Watson RD, Singh SP. Cardioversion of atrial fibrillation. Brit Med J 1996; 312: 112-5.
3. Kerber RE. Transthoracic cardioversion of atrial fibrillation and flutter: Standard techniques and new advances. Am J Cardiol 1996; 78: 22-6.
4. Kerber RE, Grayzel J, Hoyt R, et al. Transthoracic resistance in human defibrillation: Influence of body weight, chest size, serial shocks, paddle size and paddle contact pressure. Circulation 1981; 63: 676-82.
5. Kerber RE, Jensen SR, Grayzel J, et al. Elective cardioversion: Influence of paddle-electrode location and size on success rates and energy requirements. N Eng J Med 1981; 305: 659-62.
6. Dalzell GW, Anderson J, Adgey AAJ. Factors determining success and energy requirements for cardioversion of atrial fibrillation. Q J Med 1991; 78: 85-95.
7. Lown B. Electrical reversion of cardiac arrhythmias. Brit Heart J 1967; 29: 469-89.
8. Morris JJ Jr, Kong Y, North WC, et al. Experiences with "cardioversion" of atrial fibrillation and flutter. Am J Cardiol 1964; 14: 94-100.
9. Botto GL, Politi A, Bonini W, et al. External cardioversion of atrial fibrillation: role of paddle position in technical efficacy and energy requirements. Heart 1999; 82: 726-30.
10. Mathew TP, Moore A, McIntyre M, et al. Randomized comparison of electrode positions for cardioversion of atrial fibrillation. Heart 1999; 81: 576-79.
11. Mehdirad AA, Clem KL, Love CJ, et al. Improved clinical efficacy of external cardioversion by fluoroscopic electrode positioning and comparison to internal cardioversion in patients with atrial fibrillation. PACE 1999; 22: 233-7.
12. Kichhof P, Eckardt L, Loh P, et al. Anterior-posterior versus anterior-lateral electrode positions for external cardioversion of atrial fibrillation: a randomized trial. Lancet 2002; 360: 1275-9.
13. Pagen-Carlo LA, Spencer KT, Robertson CE, et al. Transthoracic defibrillation: importance of avoiding electrode placement directly on the female breast. J Am Coll Cardiol 1996; 27: 449-52.
14. Waris E, Kreus KE, Salokannel J. Factors influencing persistence of sinus rhythm after DC shock treatment of atrial fibrillation. Acta Med Scand 1971; 189: 161-6.
15. Fick M, Frykman V, Jensen-Urstad M, et al. Factors predicting success rate and recurrence of atrial fibrillation after first electrical cardioversion in patients with persistent atrial fibrillation. Clin Cardiol 2001; 24: 238-44.
16. Henry WL, Morganroth J, Pearlman AS, et al. Relation between echocardiographically determined left atrial size and atrial fibrillation. Circulation 1976; 53: 273-9.
17. Villani GQ. Effects of diltiazem pretreatment on direct-current cardioversion in patients with persistent atrial fibrillation: A single-blinded, randomized, controlled study. Am Heart J 2000; 140.
18. Capucci A, Villani GQ, Rosi A, et al. Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation. Eur Heart J 2000; 21: 66-73.
19. Alt E, Ammer R, Lehmann G, et al. Patient characteristics and underlying heart disease as predictors of recurrent atrial fibrillation after internal and external cardioversion in patients treated with oral sotalol. Am Heart J 1997; 134: 419-25.
20. Ricard P, Levy S, Trigano J, et al. Prospective assessment of the minimal energy needed for external electrical cardioversion of atrial fibrillation. Am J Cardiol 1997; 79; 815-6.
21. Kerber RE, Martins JB, Kienzle MG, et al. Energy, current, and success in defibrillation and cardioversion: clinical studies using an automated impedance-based method of energy adjustment. Circulation 1988; 77: 1038-46.
22. Joglar JA, Hamdan MH, Ramaswamy K, et al. Initial energy for elective external cardioversion of persistent atrial fibrillation. Am J Cardiol 2000: 86; 348-50.
23. Gallagher MM, Guo XH, Poloneiecki JD, et al. Initial energy setting, outcome and efficacy in direct current cardioversion of atrial fibrillation and flutter. J Am Coll Cardiol 2001; 38: 1498-504.
24. Fuster V, Ryden LE, Asinger RW, et al. ACC/AHA guidelines for the management of patients with atrial fibrillation: executive summary. Circulation 2001; 104: 2118-50.
25. Neumayr C, Hagn C, Ganzer H, et al. Plasma levels of troponin T after electrical cardioversion of atrial fibrillation and flutter. Am J Cardiol 1997; 80: 1367-9.
26. Rao ACR, Naeem N, John C, et al. Direct current cardioversion does not cause cardiac damage: evidence from cardiac troponin T estimation. Heart 1998; 80; 229-30.
27. Page RL, Kerber RE, Russell JK, et al. Biphasic versus monophasic waveform for cardioversion of atrial fibrillation. J Am Coll Cardiol 2002; 39: 1956-63.